Inventor · disambiguated record
Alan Buckler
Also filed as: BUCKLER ALAN · BUCKLER ALAN J
12 granted patents·13 pending applications·250 citations·filing 1991–2025
90Inventor score
Files withSCHOLAR ROCK INC10MASSACHUSETTS INST TECHNOLOGY5AXYS PHARM INC4BUCKLER ALAN2BOWDEN MICHAELA1
Top patents by PatentIndex Score
25 records- 0192US5350840ALocalization and characterization of the Wilms' tumor geneMASSACHUSETTS INST TECHNOLOGY·Filed 1991·Granted Sep 27, 1994·143 cites·8 claims
- 0286US5726288ALocalization and characterization of the Wilms' tumor geneMASSACHUSETTS INST TECHNOLOGY·Filed 1993·Granted Mar 10, 1998·57 cites·5 claims
- 0385US12122823B2Isoform-selective TGFB1 inhibitors and use thereofSCHOLAR ROCK INC·Filed 2021·Granted Oct 22, 2024·1 cites·13 claims
- 0478US2024016928A1Isoform-specific, context-permissive tgfb1 inhibitors and use thereofSCHOLAR ROCK INC·Filed 2023·Application pending·0 cites
- 0577US11130803B2Isoform-selective TGFβ1 inhibitors and use thereofSCHOLAR ROCK INC·Filed 2019·Granted Sep 28, 2021·1 cites·10 claims
- 0677US2025215072A1Isoform-selective tgfb1 inhibitors and use thereofSCHOLAR ROCK INC·Filed 2024·Application pending·0 cites
- 0772US6316599B1Localization and characterization of the Wilms' tumor geneMASSACHUSETTS INST TECHNOLOGY·Filed 1998·Granted Nov 13, 2001·29 cites·10 claims
- 0867US2025207129A1Methods for the treatment of neurodegenerative disordersTAKEDA PHARMACEUTICALS USA INC·Filed 2023·Application pending·0 cites
- 0964US2019209682A1Isoform-specific, context-permissive tgfb1 inhibitors and use thereofSCHOLAR ROCK INC·Filed 2019·Application pending·0 cites
- 1063US12252531B2Methods of screening for high-affinity, isoform-selective TGFβ1 inhibitorsSCHOLAR ROCK INC·Filed 2019·Granted Mar 18, 2025·0 cites·5 claims
- 1162US6087485AAsthma related genesAXYS PHARM INC·Filed 1998·Granted Jul 11, 2000·16 cites·7 claims
- 1260US2018207267A1Isoform-specific, context-permissive tgfb1 inhibitors and use thereofSCHOLAR ROCK INC·Filed 2018·Application pending·0 cites
- 1358US2025257125A1HIGH-AFFINITY, ISOFORM-SELECTIVE TGFß1 INHIBITORS AND USE THEREOFSCHOLAR ROCK INC·Filed 2025·Application pending·0 cites
- 1455US2018280476A1Diagnostic biomarkers for fibrotic disordersNOVARTIS AG·Filed 2018·Application pending·0 cites
- 1551US2016228509A9Diagnostic BioMarkers for Fibrotic DisordersBUCKLER ALAN·Filed 2013·Application pending·0 cites
- 1650US2023050148A1Tgf-beta inhibitors and use thereofSCHOLAR ROCK INC·Filed 2021·Application pending·0 cites
- 1746US6943011B2Localization and characterization of the Wilms' tumor geneMASSACHUSETTS INST TECHNOLOGY·Filed 2001·Granted Sep 13, 2005·0 cites·3 claims
- 1845US2002128196A1Localization and characterization of the Wilms' tumor geneMASSACHUSETTS INST TECHNOLOGY·Filed 2001·Application pending·0 cites
- 1944US2015051210A1Tyrosine Kinase Inhibitor Combinations and their UseTIEDT RALPH·Filed 2013·Application pending·0 cites
- 2044US2020181251A1Lrrc33 inhibitors and use thereofSCHOLAR ROCK INC·Filed 2018·Application pending·0 cites
- 2141US6017710ARAQ genes and their usesAXYS PHARM INC·Filed 1998·Granted Jan 25, 2000·3 cites·8 claims
- 2227US6100058AGap12 genes and their usesAXYS PHARM INC·Filed 1997·Granted Aug 8, 2000·0 cites·7 claims
- 2325US2012183543A1Diagnostic biomarkers for fibrotic disordersBUCKLER ALAN·Filed 2010·Application pending·0 cites
- 2424US6383792B1RAQ genes and their usesAXYS PHARM INC·Filed 1999·Granted May 7, 2002·0 cites·1 claims
- 2521US8563254B2Biomarkers of tumor pharmacodynamic responseBOWDEN MICHAELA·Filed 2010·Granted Oct 22, 2013·0 cites·1 claims
Join the waitlist — get patent alerts
Get an alert when Alan Buckler files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →